Vimarsana
Biggest News Aggregation in the World

Page 15 - Ipca Laboratories News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ipca Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ipca Laboratories Today - Breaking & Trending Today

Chloroquine Phosphate API Market Analysis and Future Prospects for 2030 - Vimarsana News

Chloroquine Phosphate API Market Analysis and Future Prospects for 2030

Chloroquine Phosphate API Market Analysis and Future Prospects for 2030

ipca laboratories share price: Stock Radar: This pharma stock is likely to top Rs 1000 levels in 1-2 months; time to buy? - Vimarsana News

ipca laboratories share price: Stock Radar: This pharma stock is likely to top Rs 1000 levels in 1-2 months; time to buy?

The stock rose from Rs 731 on 20 June to Rs 913 recorded on 20 September, which translates into an upside of 24% in 3 months. It hit a fresh 52-week high of Rs 954 on 18 September but witnessed some profit-taking thereafter, largely in line with the trend seen in broader markets

Ipca Lab acquires additional 19.29% stake in Unichem Laboratories for Rs 598 cr - Vimarsana News

Ipca Lab acquires additional 19.29% stake in Unichem Laboratories for Rs 598 cr

Ipca Labs acquired 33.38 percent of Unichem in August which triggered an open offer. Ipca Labs received the approval of the Competition Commission of India for this acquisition on July 27, 2023

Ipca Laboratories stocks: Buy Ipca Laboratories, target price Rs 970: Nagaraj Shetti - Vimarsana News

Ipca Laboratories stocks: Buy Ipca Laboratories, target price Rs 970: Nagaraj Shetti

Ipca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 23532.33 Crore) operating in Pharmaceuticals sector.

​Vodafone Idea: Vodafone Idea among 6 top stocks giving bearish signal​ - Vimarsana News

​Vodafone Idea: Vodafone Idea among 6 top stocks giving bearish signal​

​This means the average traded quantity of the stock for five days along with its cumulative open interest has increased whereas the price has decreased